Connect Biopharma Holdings Stock Price on March 31, 2022
| CNTB Stock | USD 1.54 0.02 1.32% |
If you're considering investing in Connect Stock, it is important to understand the factors that can impact its price. As of today, the current price of Connect Biopharma stands at 1.54, as last reported on the 19th of April, with the highest price reaching 1.58 and the lowest price hitting 1.45 during the day. Connect Biopharma appears to be dangerous, given 3 months investment horizon. Connect Biopharma secures Sharpe Ratio (or Efficiency) of 0.0901, which signifies that the company had a 0.0901% return per unit of risk over the last 3 months. By analyzing Connect Biopharma's technical indicators, you can evaluate if the expected return of 0.81% is justified by implied risk. Please makes use of Connect Biopharma's Risk Adjusted Performance of 0.0763, downside deviation of 7.16, and Mean Deviation of 6.66 to double-check if our risk estimates are consistent with your expectations.
At present, Connect Biopharma's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 106.1 M, whereas Common Stock is forecasted to decline to 9,500. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price Earnings Ratio is forecasted to decline to (0.39). Connect Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Connect |
Sharpe Ratio = 0.0901
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CNTB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.02 actual daily | 79 79% of assets are less volatile |
Expected Return
| 0.81 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Connect Biopharma is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Connect Biopharma by adding it to a well-diversified portfolio.
Price Book 0.737 | Book Value 16.882 | Enterprise Value -851.5 M | Enterprise Value Ebitda 0.0603 | Shares Float 16 M |
Connect Biopharma Valuation on March 31, 2022
It is possible to determine the worth of Connect Biopharma on a given historical date. On March 31, 2022 Connect was worth 3.05 at the beginning of the trading date compared to the closed value of 3.25. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Connect Biopharma stock. Still, in general, we apply an absolute valuation method to find Connect Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Connect Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Connect Biopharma's related companies.
| Open | High | Low | Close | Volume | |
04/04/2022 | 3.05 | 3.32 | 3.05 | 3.25 | 70,857 |
| 3.34 | 3.48 | 2.99 | 2.99 | 30,150 |
| Backtest Connect Biopharma | | | Connect Biopharma History | | | Connect Biopharma Valuation | Next |
Connect Biopharma Trading Date Momentum on March 31, 2022
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Connect Biopharma Fundamentals Correlations and Trends
By evaluating Connect Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Connect Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Connect financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Connect Biopharma Stock history
Connect Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Connect is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Connect Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Connect Biopharma stock prices may prove useful in developing a viable investing in Connect Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 55.1 M | 43.5 M | |
| Net Loss | -1.2 B | -1.1 B |
Connect Biopharma Quarterly Net Working Capital |
|
Connect Biopharma Stock Technical Analysis
Connect Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Connect Biopharma Period Price Range
Low | April 4, 2022
| High |
3.05 | 3.25 |
Connect Biopharma April 19, 2024 Market Strength
Market strength indicators help investors to evaluate how Connect Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Connect Biopharma shares will generate the highest return on investment. By undertsting and applying Connect Biopharma stock market strength indicators, traders can identify Connect Biopharma Holdings entry and exit signals to maximize returns
| Accumulation Distribution | 5762.47 | |||
| Daily Balance Of Power | 0.7407 | |||
| Rate Of Daily Change | 1.07 | |||
| Day Median Price | 3.18 | |||
| Day Typical Price | 3.21 | |||
| Price Action Indicator | 0.17 | |||
| Period Momentum Indicator | (1.71) |
Connect Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Connect Biopharma's price direction in advance. Along with the technical and fundamental analysis of Connect Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Connect to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0763 | |||
| Jensen Alpha | 0.8816 | |||
| Total Risk Alpha | 0.1108 | |||
| Sortino Ratio | 0.1254 | |||
| Treynor Ratio | 0.7532 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Connect Biopharma Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Connect Stock analysis
When running Connect Biopharma's price analysis, check to measure Connect Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Connect Biopharma is operating at the current time. Most of Connect Biopharma's value examination focuses on studying past and present price action to predict the probability of Connect Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Connect Biopharma's price. Additionally, you may evaluate how the addition of Connect Biopharma to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is Connect Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Connect Biopharma. If investors know Connect will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Connect Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.53) | Return On Assets (0.29) | Return On Equity (0.52) |
The market value of Connect Biopharma is measured differently than its book value, which is the value of Connect that is recorded on the company's balance sheet. Investors also form their own opinion of Connect Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Connect Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Connect Biopharma's market value can be influenced by many factors that don't directly affect Connect Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Connect Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Connect Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Connect Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.